Michael Rabovsky, MD

216.839.3900

Michael Rabovsky, MD

Appointed: 2000

Michael Rabovsky, MD
Department: Family Medicine
Department Chair
Location: Beachwood Family Health Center
Mail Code BD10
26900 Cedar Road
Beachwood, OH 44122
WorkAppointment:216.839.3900
WorkFax:216.839.3910
Surgeon:
No
Treats:
Both Adults and Children & Adolescents

Biographical Sketch

Michael Rabovsky, MD, is Interim Chairman of the Department of Family Medicine in the Medicine Institute at Cleveland Clinic and Medical Director of the Cleveland Clinic Beachwood Family Health and Surgery Center. His specialty interests include healthcare screening, preventive medicine and general family medicine.

He attended medical school at the University of Maryland School of Medicine, Baltimore, Md., and he completed his residency at University Hospitals of Cleveland, Cleveland, Ohio.

Professional Highlights

Preceptor of medical students, 500 hour award, Case Western Reserve University School of Medicine

Education & Fellowships

Residency - University Hospitals of Cleveland
Family Practice
Cleveland, OH USA
1984
Medical School - University of Maryland Medical Center
Baltimore, MD USA
1981
Undergraduate - University of Pennsylvania
Philadelphia, PA USA
1976

Certifications

  • Family Medicine

Specialty Interests

General Family Medicine, health care screening, Preventive Medicine

Awards & Honors

  • Top Docs, Best Doctors, Inc., 2000-2001, 2002-2003, 2003-2004, 2005-2006, 2007-2008
  • Best Primary Care Doctors, Town and Country magazine, 2000
  • Best Doctors in America, midwest region, 1995-1997, 1997-1999
  • Top Doctors, Castle, Connolly Medical Ltd., 2001, 2002, 2008
  • Top Doctors, Northern Ohio Live, 2005

Memberships

  • American Academy of Family Physicians
  • Cleveland Academy of Family Practice

Treatment & Services

Industry Relationships

Cleveland Clinic physicians and scientists may collaborate with the pharmaceutical or medical device industries to help develop medical breakthroughs or provide medical expertise or education. Cleveland Clinic strives to make scientific advances that will benefit patient care and support outside relationships that promise public benefit. In order for the discoveries of Cleveland Clinic physicians' and scientists' laboratories and investigations to benefit the public, these discoveries must be commercialized in partnership with industry. As experts in their fields, Cleveland Clinic physicians and scientists are often sought after by industry to consult, provide expertise and education.

To assure professional and commercial integrity in such matters, Cleveland Clinic maintains a program that reviews these collaborations and, when appropriate, puts measures in place to minimize bias that may result from ties to industry. The Cleveland Clinic publicly discloses the names of companies when (i) its physicians/scientists receive $5,000 or more per year (or, in rare cases, equity or stock options) for speaking and consulting, (ii) its physicians/scientists serve as a fiduciary, (iii) its physicians/scientists receive or have the right to receive royalties or (iv) its physicians/scientists hold any equity interest for the physician's/scientist's role as inventor, discoverer, developer, founder or consultant.* In publicly disclosing this information, the Cleveland Clinic tries to provide information as accurately as possible about its physicians' and scientists' connections with industry.

As of 7/23/2014, Dr. Rabovsky has reported no financial relationship with industry that is applicable to this listing. In general, patients should feel free to contact their doctor about any of the relationships and how the relationships are overseen by the Cleveland Clinic. To learn more about the Cleveland Clinic's policies on collaborations with industry and innovation management, go to our Integrity in Innovation page.

Public Health Service-Reportable Financial Conflicts of Interest. Cleveland Clinic scientists and physicians engage in basic, translational and clinical research activities, working to solve health problems, enhance patient care and improve quality of life for patients. Interactions with industry are essential to bringing the researchers’ discoveries to the public, but can present the potential for conflicts of interest related to their research activities. Click here to view a listing of instances where Cleveland Clinic has identified a Public Health Service (PHS)-Reportable Financial Conflict of Interest and has put measures in place to ensure that, to the extent possible, the design, conduct and reporting of the research is free from bias.

* Cleveland Clinic physicians and scientists subscribe to the guidance presented in the PhRMA Code on Interactions with Healthcare Professionals and the AdvaMed Code of Ethics on Interactions with Health Care Professionals. As such, gifts of substantial value are generally prohibited.

Languages Spoken

  • English
Cleveland Clinic Mobile Site